Catheter Precision VTAK Estimates

NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT
Analyst Estimates

Catheter Precision, Inc. Revenue Estimates

Periods 14
Next Period Q2 25
Consensus 630,708.00

Analysts expect Catheter Precision, Inc. to report revenue of 630,708.00 for Q2 25, against a range of 583,451.57 to 677,964.43. The most recent reported quarter, Q1 26, came in at 432,000.00, a 74.5% miss against the 1.70 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 96,000.00149,000.00143,000.00-226,000.00-432,000.00------
High Estimate 102,032.11313,045.29301,874.22677,964.431.17 M1.67 M1.86 M2.05 M3.15 M3.69 M1.89 M3.20 M4.14 M
Low Estimate 84,210.89264,757.71267,540.78583,451.571.07 M1.49 M1.53 M1.83 M2.77 M3.43 M1.72 M2.63 M3.81 M
Consensus Estimate 93,121.50288,901.50284,707.50630,708.001.12 M1.58 M1.70 M1.94 M2.96 M3.56 M1.81 M2.92 M3.97 M
Analyst Estimates

Catheter Precision, Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q4 24
Consensus -39.74

Analysts expect Catheter Precision, Inc. to report earnings per share of -39.74 for Q4 24, against a range of -42.75 to -36.73. The most recent reported quarter, Q3 24, came in at -38.19, a 4.7% beat against the -40.06 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -38.19--------
High Estimate -37.37-36.73-33.68-29.70-24.15-20.71-20.10-19.11-12.06
Low Estimate -42.75-42.75-37.02-34.40-27.39-23.19-22.94-20.37-13.04
Consensus Estimate -40.06-39.74-35.35-32.05-25.77-21.95-21.52-19.74-12.55